MYCN is a novel oncogenic target in adult B ‐ALL that activates the Wnt/β‐catenin pathway by suppressing DKK3

Journal of Cellular and Molecular Medicine, EarlyView.

Source: Journal of Cellular and Molecular Medicine - April 19, 2018 Category: Molecular Biology Authors: Desheng Kong , Linlin Zhao , Lili Sun , Shengjin Fan , Huibo Li , Yanqiu Zhao , Zhibo Guo , Leilei Lin , Lin Cui , Ke Wang , Wenjia Chen , Yihui Zhang , Jin Zhou , Yinghua Li Source Type: research